Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Optimizing effector functions of monoclonal antibodies via tailored N-glycan engineering using a dual landing pad CHO targeted integration platform.

Scientific reports·2023

Same author

A Scalable Suspension Platform for Generating High-Density Cultures of Universal Red Blood Cells from Human Induced Pluripotent Stem Cells.

Stem cell reports·2020

Same author

Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson's disease.

Stem cell research & therapy·2020

Same author

Influencing the Fate of Cardiac and Neural Stem Cell Differentiation Using Small Molecule Inhibitors of ALK5.

Stem cells translational medicine·2018

Same author

Immobilization of vitronectin-binding heparan sulfates onto surfaces to support human pluripotent stem cells.

Journal of biomedical materials research. Part B, Applied biomaterials·2017

Same author

Immature Midbrain Dopaminergic Neurons Derived from Floor-Plate Method Improve Cell Transplantation Therapy Efficacy for Parkinson's Disease.

Stem cells translational medicine·2017

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

Efficient Neural Differentiation using Single-Cell Culture of Human Embryonic Stem Cells

Efficient Neural Differentiation using Single-Cell Culture of Human Embryonic Stem Cells

Published on: January 18, 2020

Human embryonic stem cell technology: large scale cell amplification and differentiation.

Steve K W Oh¹, Andre B H Choo

¹Stem Cell Group, Bioprocessing Technology Institute, 20 Biopolis Way, #06 - 01 Centros, 138668, Singapore, Singapore, steve_oh@bti.a-star.edu.sg.

|November 13, 2008

Summary

This summary is machine-generated.

Human embryonic stem cells (hESC) offer therapeutic potential for diseases like Parkinson's and diabetes. Developing methods to expand and differentiate hESC is crucial for realizing their clinical applications.

More Related Videos

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol

Published on: July 25, 2016

Robust Generation of Hepatocyte-like Cells from Human Embryonic Stem Cell Populations

Robust Generation of Hepatocyte-like Cells from Human Embryonic Stem Cell Populations

Published on: October 26, 2011

Related Experiment Videos

Last Updated: Jun 28, 2026

Efficient Neural Differentiation using Single-Cell Culture of Human Embryonic Stem Cells

Efficient Neural Differentiation using Single-Cell Culture of Human Embryonic Stem Cells

Published on: January 18, 2020

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol

Published on: July 25, 2016

Robust Generation of Hepatocyte-like Cells from Human Embryonic Stem Cell Populations

Robust Generation of Hepatocyte-like Cells from Human Embryonic Stem Cell Populations

Published on: October 26, 2011

Area of Science:

Stem cell biology
Regenerative medicine
Developmental biology

Background:

Embryonic stem cells (ESC) are a promising source for cell-based therapies, potentially treating conditions such as Parkinson's Disease and diabetes.
Deriving pure cell populations from ESC for therapeutic use presents significant biological and technical challenges.
Advancing ESC technology requires substantial investment in expansion and differentiation techniques.

Purpose of the Study:

To review current assays for characterizing human ESC (hESC).
To examine defined, feeder-free culture conditions for undifferentiated hESC growth.
To explore quality control measures, expansion/differentiation methods, and scaling-up strategies for hESC therapies.

Main Methods:

Literature review of standard assays for hESC characterization.
Analysis of current feeder-free culture systems for hESC maintenance.
Evaluation of existing expansion and differentiation protocols.
Discussion of quality control and scale-up considerations for therapeutic applications.

Main Results:

Standard assays for hESC characterization are documented.
The status of defined, feeder-free culture conditions for hESC is reviewed.
Quality control requirements for hESC growth are examined.
Current expansion and differentiation methods are discussed, alongside potential scale-up routes.

Conclusions:

Significant technological development is needed to translate the therapeutic promise of hESC into clinical reality.
Standardized characterization, defined culture conditions, and robust quality control are essential for hESC applications.
Scaling up hESC differentiation presents challenges but is vital for meeting therapeutic demands.